Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 125
Filtrar
1.
Clin Radiol ; 2024 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-39198110

RESUMEN

AIM: Climate change poses a major threat to human health, with significant contributions from healthcare systems, with the UK National Health Service (NHS) accounting for 4% of national CO2 emissions. Radiology departments, with high energy consumption from heating, ventilation, cooling (HVAC), and scanners, also contribute significantly. Workstations, though less power-intensive than scanners, are numerous and offer an avenue for emission reduction potential. This study investigates the impact of an automatic power-off/on protocol for radiology workstations at an acute hospital trust on energy consumption, carbon emissions, and financial savings. MATERIALS AND METHODS: Data from 88 reporting workstations were collected on power usage, CO2 emissions, and the associated energy cost before and after implementing an automatic shutdown protocol, which ensured workstations were turned off out of hours and over weekends. RESULTS: Average weekly workstation on-time fell from 148 to 75.5 hours, resulting in an annual energy saving of 17 MWh, equivalent to a reduction of 3.4 tonnes CO2 equivalent and a financial saving of £5000. No complaints or issues with workflow disruption were reported. CONCLUSION: This intervention demonstrates a significant reduction in emissions and energy costs without workflow disruption, offering an easy and replicable sustainability measure for radiology departments. While savings are modest compared to HVAC and scanner emissions, the protocol's simplicity and effectiveness in addressing human factors in power management highlight its potential. Broader application across hospital networks could yield substantial environmental and financial benefits. These findings contribute to the ongoing efforts to improve sustainability within radiology and health care.

2.
Br Poult Sci ; 65(3): 265-272, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38785186

RESUMEN

1. The potential growth of the chemical and physical components of males and females of the Cobb 700 strain was measured from hatch to 15 weeks of age.2. A four-phase ad libitum feeding programme was used to feed 200 chicks of each sex. All birds were weighed weekly. Ten birds per sex were sampled at 0, 7, 14, 28, 42, 56, 70, 84 and 105 d of age. They were weighed before and after plucking to determine the weight of feathers. Physical parts were measured on defeathered birds, whereafter these components were combined, minced, freeze dried to measure water content, and then analysed for protein, lipid and ash content.3. Mature body weights of males and females averaged 8.38 and 6.94 kg, respectively, mature body protein weights averaged 1.48 and 1.19 kg and mature body lipid contents averaged 1.08 and 1.54 kg, respectively.4. Rates of maturing of the empty feather-free body weights of males and females averaged 0.0417 and 0.0402/d, respectively. All chemical and physical components within a sex, other than feathers, had the same rate of maturing. The rate of maturing of feathers, calculated by iteration, in males was lower than in females (0.0324 vs. 0.0357/d) and the mature weight was higher (435 vs. 372 g).5. The ratios of the chemical components to feather-free body protein at maturity for males and females were, for water, 3.80 and 3.34; for lipid, 0.73 and 1.29; and for ash, 0.13 and 0.19, respectively. Separate equations were required for males and females to describe the allometric relationship between lipid and protein in the feather-free body.6. Mature body weights of broilers in this trial were considerably higher than those measured using the same protocol 28 years ago, whereas rates of maturing have remained the same.


Asunto(s)
Composición Corporal , Pollos , Plumas , Animales , Masculino , Femenino , Plumas/química , Pollos/crecimiento & desarrollo , Pollos/genética , Pollos/fisiología , Genotipo , Peso Corporal
3.
J Laryngol Otol ; 137(8): 938-941, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-36750228

RESUMEN

BACKGROUND: Cholesteatomas present a high risk for residual and recurrent disease, and the surveillance of post-operative patients can be challenging. Diffusion-weighted magnetic resonance imaging is becoming the preferred method for investigating recidivism; however, false positive imaging findings increase the risk of patients undergoing unnecessary second look surgery. CASE REPORTS: This study reports two patients with false positive diffusion restriction associated with cartilage grafts that mimicked cholesteatoma and resulted in second look surgery with no disease found at operation. This study also discusses the related medical literature, including potential causes of abnormal diffusion restriction and methods to negate this. CONCLUSION: Caution should be exercised when considering second look surgery in the presence of a cartilage graft and a high confidence of disease clearance. A multi-disciplinary approach is recommended for the operating surgeon to review the images with a radiologist.


Asunto(s)
Colesteatoma del Oído Medio , Humanos , Colesteatoma del Oído Medio/diagnóstico por imagen , Colesteatoma del Oído Medio/cirugía , Imagen de Difusión por Resonancia Magnética/métodos , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , Recurrencia , Sensibilidad y Especificidad , Femenino , Persona de Mediana Edad
4.
J Laryngol Otol ; 137(2): 138-142, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-35081998

RESUMEN

OBJECTIVE: Pulsatile tinnitus can be a symptom of vascular pathology. However, many of these pathologies present as incidental findings on scanning for unrelated symptoms. This study investigated whether the pathologies attributed to pulsatile tinnitus could instead be considered incidental findings. METHODS: This retrospective study evaluated imaging results of 272 pulsatile tinnitus cases for clinically relevant pathologies, and examined correlations between the site of symptoms and the imaging findings. RESULTS: Of 272 patients, 238 (88 per cent) had normal scans, 17 (6 per cent) had clinically insignificant incidental findings, and 18 (7 per cent) had findings requiring further investigation or intervention; regarding these latter 18 patients, findings for 8 patients (42 per cent) did not correlate with the symptomatic side. The rates of intracranial aneurysm and arteriovenous malformation in the pulsatile tinnitus group were comparable to those in normal populations. CONCLUSION: The comparable rates of vascular abnormalities within the symptomatic pulsatile tinnitus group, plus clinically relevant findings contralateral to symptoms, suggest that vascular pathologies could be incidental findings rather than causes of pulsatile tinnitus. Evaluation is recommended of the effectiveness of the new National Institute for Health and Care Excellence guidelines for pulsatile tinnitus investigation.


Asunto(s)
Acúfeno , Humanos , Acúfeno/etiología , Acúfeno/diagnóstico , Estudios Retrospectivos
5.
Clin Radiol ; 77(8): e667-e672, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-35688772

RESUMEN

AIM: To assess attitudes towards the climate emergency among radiology staff and to identify current practices that may contribute towards the National Health Service (NHS) net zero target. MATERIALS AND METHODS: An online survey of radiology staff was conducted assessing current attitudes to the climate emergency. Further questions focused on staff travel, home working, virtual conferences, and recycling. RESULTS: Two hundred and forty-two responses were received from all staff groups within radiology. There were high levels of concern about the climate emergency among radiology staff. Active travel accounts for a relatively small proportion of commuting related to provision of radiology services. Some energy-saving measures are implemented commonly in radiology departments but these are likely to account for only a small proportion of energy use within a department. CONCLUSION: There is significant scope for reducing the carbon footprint of radiology services by reducing travel, both for work and for radiology education. We discuss the potential for large savings related to energy-saving measures.


Asunto(s)
Servicio de Radiología en Hospital , Radiología , Humanos , Radiografía , Radiología/educación , Medicina Estatal , Reino Unido
6.
J Laryngol Otol ; 136(8): 775-782, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34641994

RESUMEN

BACKGROUND: Sudden hearing loss, or progressive hearing loss occurring over months to years, are well-established presentations. However, little is described in the medical literature on how to approach patients presenting with a rapidly progressive hearing loss occurring over weeks. This study aimed to evaluate the clinical significance of patients presenting with rapidly progressive hearing loss. METHODS: A case of rapidly progressive hearing loss occurring over 12 weeks is presented. A PubMed literature review was performed to determine the evidence-based differential diagnoses for rapidly progressive hearing loss. RESULTS: Fifteen causes were identified for rapidly progressive hearing loss: intracranial aetiologies (meningioma, lymphoma, metastatic deposit, cavernous angioma, meningitis, superficial siderosis); paraneoplastic syndrome (small cell lung carcinoma, thymoma); inflammatory or autoimmune disorders (autoimmune inner-ear disease, sarcoidosis, vasculitis, Sjögren's syndrome); infective disorders (syphilis, human immunodeficiency virus); and medication-induced causes. CONCLUSION: Rapidly progressive hearing loss should be considered a 'red flag' symptom that warrants urgent action. Most causes are systemic or sinister in nature, and the patient's hearing loss can potentially be reversed.


Asunto(s)
Enfermedades Autoinmunes , Sordera , Pérdida Auditiva Sensorineural , Pérdida Auditiva Súbita , Sordera/complicaciones , Diagnóstico Diferencial , Pérdida Auditiva Sensorineural/diagnóstico , Pérdida Auditiva Súbita/complicaciones , Pérdida Auditiva Súbita/etiología , Humanos
7.
Int J Parasitol ; 51(8): 599-611, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-33722681

RESUMEN

Protozoan parasites are single-celled eukaryotic organisms that cause significant human disease and pose a substantial health and socioeconomic burden worldwide. They are responsible for at least 1 million deaths annually. The treatment of such diseases is hindered by the ability of parasites to form latent cysts, develop drug resistance, or be transmitted by insect vectors. Additionally, these pathogens have developed complex mechanisms to alter host gene expression. The prevalence of these diseases is predicted to increase as climate change leads to the augmentation of ambient temperatures, insect ranges, and warm water reservoirs. Therefore, the discovery of novel treatments is necessary. Transcription factors lie at the junction of multiple signalling pathways in eukaryotes and aberrant transcription factor function contributes to the progression of numerous human diseases including cancer, diabetes, inflammatory disorders and cardiovascular disease. Transcription factors were previously thought to be undruggable. However, due to recent advances, transcription factors now represent appealing drug targets. It is conceivable that transcription factors, and the pathways they regulate, may also serve as targets for anti-parasitic drug design. Here, we review transcription factors and transcriptional modulators of protozoan parasites, and discuss how they may be useful in drug discovery. We also provide information on transcription factors that play a role in stage conversion of parasites, TATA box-binding proteins, and transcription factors and cofactors that participate with RNA polymerases I, II and III. We also highlight a significant gap in knowledge in that the transcription factors of some of parasites have been under-investigated. Understanding parasite transcriptional pathways and how parasites alter host gene expression will be essential in discovering innovative drug targets.


Asunto(s)
Parásitos , Preparaciones Farmacéuticas , Animales , Eucariontes , Regulación de la Expresión Génica , Humanos , Proteínas Protozoarias , Factores de Transcripción/genética
8.
Gen Hosp Psychiatry ; 55: 77-83, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30447477

RESUMEN

OBJECTIVE: Veterans in mental health care have high rates of firearm-related suicide; reducing firearm access during high-risk periods could save lives. We assessed veteran patients' attitudes towards voluntary interventions to reduce access. METHODS: Descriptive data came from surveys mailed to random samples of veterans receiving mental health care in five geographically diverse VA facilities. Survey items inquired about the acceptability of seven voluntary health system interventions to address firearm access, ranging from lower-intensity interventions that addressed safety but might not reduce access (i.e., clinician screening; distribution of gunlocks) to interventions substantially limiting access (i.e., storage of firearms offsite; gun disposal). Mailings occurred between 5/11/15 and 10/19/15; 677 of 1354 veterans (50%) returned the surveys. RESULTS: 93.2% of respondents endorsed one or more health system interventions addressing firearm access; 75.0% endorsed interventions substantially limiting access. Although veterans with household firearms were less likely to endorse interventions, fully 50.4% would personally participate in at least one intervention that substantially limited access. DISCUSSION: A majority of veterans in VA mental health care endorse voluntary health system interventions addressing firearm access during high-risk periods for suicide. Approximately half of veterans with firearms would personally participate in an intervention that substantially limited firearm access.


Asunto(s)
Armas de Fuego , Servicios de Salud Mental/estadística & datos numéricos , Aceptación de la Atención de Salud/estadística & datos numéricos , Seguridad del Paciente , Prevención del Suicidio , Veteranos/estadística & datos numéricos , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estados Unidos , United States Department of Veterans Affairs
10.
Poult Sci ; 97(2): 549-556, 2018 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-29121338

RESUMEN

An experiment was conducted to investigate the impact of ß-mannanase inclusion on growth performance, viscosity, and energy utilization in broilers fed diets varying in galactomannan (GM) concentrations. Treatments were arranged as a 3 (GM concentration) × 3 (ß-mannanase inclusion) factorial randomized complete block design with 12 replicates of 29 male broilers per replicate for a 42-d experiment. Efforts were made to reduce the amount of soybean meal, and thus GM, in the basal diet with guar gum included at 0, 0.21, or 0.42% to achieve a GM supplementation of 1,500 and 3,000 ppm, respectively. Beta-mannanase was included at 0, 200, or 400 g/ton. Broilers were fed a starter (d 0 to 14), grower (d 15 to 28), and finisher diets (d 29 to 42). Growth performance was monitored and ileal contents collected on d 14, 28, and 42 to determine ileal digestible energy (IDE) and intestinal viscosity. Increasing levels of GM negatively (P < 0.05) influenced body weight (BW) following the starter and grower periods and increased (P < 0.01) mortality corrected feed conversion ratio (FCR) throughout the study. Reduced growth performance was associated with increased (P < 0.05) intestinal viscosity and decreased (P < 0.05) IDE when GM inclusion was increased. Inclusion of ß-mannanase in diets containing supplemental GM on d 28, increased average BW to levels similar to diets without supplemental GM. Improvements in FCR were also observed with ß-mannanase inclusion in diets containing supplemental GM. Ileal digestible energy was increased (P < 0.05) with the addition of ß-mannanase on d 28 of age. Multiple interactions in growth performance, intestinal viscosity, and IDE were associated with ß-mannanase administration. In conclusion, ß-mannanase improved IDE, reduced intestinal viscosity, and improved growth performance; however, the observed benefit was dependent upon dietary GM concentration.


Asunto(s)
Fenómenos Fisiológicos Nutricionales de los Animales/efectos de los fármacos , Pollos/crecimiento & desarrollo , Pollos/metabolismo , Mananos/metabolismo , beta-Manosidasa/metabolismo , Alimentación Animal/análisis , Animales , Dieta/veterinaria , Suplementos Dietéticos/análisis , Digestión/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Metabolismo Energético , Galactosa/análogos & derivados , Íleon/efectos de los fármacos , Íleon/fisiología , Intestinos/fisiología , Masculino , Mananos/administración & dosificación , Distribución Aleatoria , Viscosidad
11.
Clin Exp Immunol ; 184(3): 308-17, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-26934060

RESUMEN

The aim of this study was to evaluate prospectively cytokine levels and disease activity in juvenile idiopathic arthritis (JIA) patients treated with and without tumour necrosis factor (TNF)-α inhibitors. TNF-α inhibitor-naive JIA subjects were followed prospectively for 6 months. Cytokine levels of TNF-α, interleukin (IL)-1ß, IL-6, IL-8, IL-10 and IL-17 were measured at baseline for JIA subjects and healthy controls (HCs). Cytokine levels were then measured at four time-points after initiation of TNF-α inhibition for anti-TNF-α-treated (anti-TNF) JIA subjects, and at two subsequent time-points for other JIA (non-TNF) subjects. JIA disease activity by Childhood Health Assessment Questionnaire (CHAQ) disability index/pain score and physician joint count/global assessment was recorded. Sixteen anti-TNF, 31 non-TNF and 16 HCs were analysed. Among JIA subjects, those with higher baseline disease activity (subsequent anti-TNFs) had higher baseline TNF-α, IL-6 and IL-8 than those with lower disease activity (non-TNFs) (P < 0·05). TNF-α and IL-10 increased, and IL-6 and IL-8 no longer remained significantly higher after TNF-α inhibitor initiation in anti-TNF subjects. Subgroup analysis of etanercept versus adalimumab-treated subjects showed that TNF-α and IL-17 increased significantly in etanercept but not adalimumab-treated subjects, despite clinical improvement in both groups of subjects. JIA subjects with increased disease activity at baseline had higher serum proinflammatory cytokines. TNF-α inhibition resulted in suppression of IL-6 and IL-8 in parallel with clinical improvement in all anti-TNF-treated subjects, but was also associated with elevated TNF-α and IL-17 in etanercept-treated subjects.


Asunto(s)
Adalimumab/uso terapéutico , Antirreumáticos/uso terapéutico , Artritis Juvenil/tratamiento farmacológico , Etanercept/uso terapéutico , Regulación de la Expresión Génica/efectos de los fármacos , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Adolescente , Artritis Juvenil/genética , Artritis Juvenil/inmunología , Artritis Juvenil/patología , Estudios de Casos y Controles , Niño , Femenino , Regulación de la Expresión Génica/inmunología , Humanos , Interleucina-10/genética , Interleucina-10/inmunología , Interleucina-17/genética , Interleucina-17/inmunología , Interleucina-1beta/genética , Interleucina-1beta/inmunología , Interleucina-6/genética , Interleucina-6/inmunología , Interleucina-8/genética , Interleucina-8/inmunología , Masculino , Estudios Prospectivos , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología , Adulto Joven
12.
Intern Med J ; 42(7): 786-93, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21790922

RESUMEN

BACKGROUND: Globally, cardiovascular disease (CVD) is the leading cause of death. Beta-blocker medications have well-established survival benefit for myocardial infarction and heart failure. However, CVD frequently coexists with chronic obstructive airways disease (COPD), a disease in which beta-blockers are traditionally avoided. AIM: We sought to investigate the adverse respiratory effects associated with long-term beta-blocker treatment in patients with cardiac disease, and presumed high risk of COPD. METHODS: In this prospective cohort study, patients admitted with acute cardiac disease were recruited from the cardiology unit of a tertiary referral hospital. The treating cardiologist determined beta-blocker treatment, independent of the study. Repeated measures of spirometry and respiratory symptom scores were assessed over 12 months. Respiratory exacerbations, cardiac events and survival were recorded over 6 years. Outcomes were compared according to beta-blocker exposure. RESULTS: Sixty-four subjects participated, 30 of whom received beta-blockers. Beta-blockers did not adversely affect spirometry, respiratory symptoms or survival. However, considering two categories of respiratory exacerbations (symptom-based vs treated), subjects taking beta-blockers accumulated increased annual risk (relative risk (RR) 1.30, 95% confidence interval (CI) 1.11-1.53, P= 0.001 and RR 1.37, 95% CI 1.09-1.72, P= 0.008) and concluded with overall increased risk (RR 3.67, 95% CI 1.65-8.18, P= 0.001 and RR 4.03, 95% CI 1.26-12.9, P= 0.019), when compared with the group not taking beta-blockers. CONCLUSION: Long-term beta-blocker treatment did not adversely affect lung function, respiratory symptom scores or survival, but was associated with increased risk of respiratory exacerbations.


Asunto(s)
Antagonistas Adrenérgicos beta/efectos adversos , Cardiopatías/tratamiento farmacológico , Cardiopatías/epidemiología , Trastornos Respiratorios/inducido químicamente , Trastornos Respiratorios/epidemiología , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Cardiopatías/fisiopatología , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Trastornos Respiratorios/fisiopatología , Espirometría/tendencias , Resultado del Tratamiento
14.
Science ; 330(6005): 762-3, 2010 Nov 05.
Artículo en Inglés | MEDLINE | ID: mdl-21051619
15.
Br J Radiol ; 81(967): 537-44, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18347026

RESUMEN

We describe a prospective evaluation of the safety of peripheral angiography procedures performed on day-case patients in a dedicated radiological nurse-led and administrated unit. Patients referred for peripheral vascular angiography, over a 10-year period, were pre-assessed by a radiology specialist nurse in a nurse-led clinic. Radiologists performed all procedures, whereas radiology specialist nurses were responsible for patient care before, during and after angiography and during the 24 h follow-up. Procedures were divided into diagnostic or interventional; complications were divided into immediate or delayed (24 h follow-up) either requiring hospital admission (major) or day-case unit management (minor). Patient acceptability was assessed using a standard questionnaire. Cost analysis was also performed. 401 day-case peripheral angiography procedures (144 diagnostic and 257 interventional) were performed in 310 patients. 109/401 (27.2%) procedures were performed on patients with diabetes mellitus. In diagnostic studies, 16/144 (11.1%) immediate and 6/144 (4.2%) delayed complications occurred whereas, in interventional studies, 65/257 (25.3%) immediate and 13/257 (5.1%) delayed complications were noted. A major complication occurred in 17/257 (6.6%) of patients in the interventional group and 3/144 (2.1%) in the diagnostic group. Puncture site haematoma was the most common complication. Nurse-led care was acceptable to the patient, with a high level of patient satisfaction seen. In conclusion, day-case diagnostic and interventional peripheral angiography procedures can be performed safely in a specialist nurse-led and administrated unit, with complication rates being within the accepted guidelines.


Asunto(s)
Atención Ambulatoria/estadística & datos numéricos , Enfermedades Vasculares Periféricas/diagnóstico por imagen , Adulto , Anciano , Anciano de 80 o más Años , Atención Ambulatoria/economía , Angiografía/efectos adversos , Angiografía/economía , Angiografía/enfermería , Costos y Análisis de Costo , Femenino , Hospitalización/economía , Hospitalización/estadística & datos numéricos , Humanos , Londres , Masculino , Persona de Mediana Edad , Satisfacción del Paciente , Enfermedades Vasculares Periféricas/economía , Enfermedades Vasculares Periféricas/enfermería , Estudios Prospectivos
16.
Arch Pediatr ; 15(3): 253-62, 2008 Mar.
Artículo en Francés | MEDLINE | ID: mdl-18321688

RESUMEN

UNLABELLED: During the southern-hemispheric 2005-2006 summer, Reunion Island was struck by an epidemic of Chikungunya (Chik), which affected more than a third of the overall population. OBJECTIVES: Our objective was to describe pediatric cases of Chick. MATERIAL AND METHODS: We conducted a retrospective descriptive monocentric study of confirmed pediatric cases of Chik recruited at Saint-Denis' departmental hospital during the peak of the epidemic (January 1st to April 30th 2006). RESULTS: Eighty-six children aged 10 days to 18 years were included. In addition to the typical clinical presentation, we observed other phenotypes. Well-known complicated forms with neurologic, cardiac, gastro-intestinal (plus dehydration) involvement were thoroughly investigated using modern medical technology. We observed 2 fatal cases of acute disease in 9-year-old children: death resulted from a central nervous system insult in one case, and multisystemic neurological, cardiac, haemorrhagic involvement in another. Severe acute presentations requiring hospital admission involved mainly children aged less than 6 months, and those with cardiac, skin and neurologic impairment. The study identified 3 cases of epidermolysis bullosa, which to our knowledge, have never been described previously. CONCLUSION: Chik in children warrants further research in order to propose early and appropriate treatments to avoid complications.


Asunto(s)
Infecciones por Alphavirus/epidemiología , Virus Chikungunya , Adolescente , Infecciones por Alphavirus/complicaciones , Niño , Preescolar , Demografía , Hospitalización/estadística & datos numéricos , Humanos , Lactante , Recién Nacido , Estudios Retrospectivos , Reunión/epidemiología
17.
Phys Rev Lett ; 97(9): 093202, 2006 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-17026360

RESUMEN

Most of the experimental and theoretical studies of electron-impact ionization of atoms, referred to as (e, 2e), have concentrated on the scattering plane. The assumption has been that all the important physical effects will be observable in the scattering plane. However, very recently it has been shown that, for C6+-helium ionization, experiment and theory are in nice agreement in the scattering plane and in very bad agreement out of the scattering plane. This lack of agreement between experiment and theory has been explained in terms of higher-order scattering effects between the projectile and target ion. We have examined electron-impact ionization of magnesium and have observed similar higher-order effects. The results of the electron-impact ionization of magnesium indicate the possible deficiencies in the calculation of fully differential cross sections in previous heavy particle ionization work.

19.
Arch Pediatr ; 12 Suppl 1: S67-71, 2005 Apr.
Artículo en Francés | MEDLINE | ID: mdl-15893244

RESUMEN

AIM OF THE STUDY: To evaluate mefloquine versus halofantrine in children suffering from acute uncomplicated falciparum malaria. MATERIAL AND METHODS: Prospective non randomized study in hospitalized children during one year. Acute falciparum malaria was defined by fever and a positive thin and/or thick smear. Malaria was presumed to have been contracted in Comoros archipelago and/or Madagascar 6 months previously. Patients were excluded, when quinine had to be used, according to World Health Organization's severity criteria. RESULTS: Forty-nine children were included: 29 were treated with halofantrine and 20 with mefloquine. Patients features in the two groups of treatment were identical, with exception for the mean time between first clinical signs and diagnosis (shorter in mefloquine group). Fever's and hospitalization's duration under treatment were similar. An increase in QTc interval was frequently observed in patients treated with halofantrine (56 versus 0%), although patients with mefloquine experienced vomiting (45 versus 0%). Relapses seemed to be more frequent with halofantrine (14 versus 0%). DISCUSSION: Halofantrine and mefloquine are efficient for falciparum malaria treatment in our pediatric series, despite a high rate of adverse events. Mefloquine's tolerance may probably be improved with changes in regimen and dose. Relapses are more frequent with a single first treatment of halofantrine, than with mefloquine. Unfortunately, features of a second halofantrine treatment are not defined.


Asunto(s)
Antimaláricos/efectos adversos , Antimaláricos/uso terapéutico , Malaria Falciparum/tratamiento farmacológico , Mefloquina/efectos adversos , Mefloquina/uso terapéutico , Fenantrenos/efectos adversos , Fenantrenos/uso terapéutico , Adolescente , Niño , Preescolar , Femenino , Humanos , Lactante , Síndrome de QT Prolongado/inducido químicamente , Masculino , Resultado del Tratamiento
20.
Mod Healthc ; 33(43): 29-32, 2003 Oct 27.
Artículo en Inglés | MEDLINE | ID: mdl-14626614

RESUMEN

Hospitals are facing competition from myriad freestanding players in the outpatient market. It's a fight hospitals can't afford to lose because they often use outpatient profits to cover losses in other service lines. Indeed about 60% of the average hospital's operating margin depends on outpatient revenues. In this session of Straight Talk, we examine how hospitals can build and finance outpatient services with physicians, increasing their competitiveness in increasingly competitive markets.


Asunto(s)
Convenios Médico-Hospital , Servicio Ambulatorio en Hospital/organización & administración , Administración de Línea de Producción , Financiación del Capital , Toma de Decisiones en la Organización , Administración Financiera de Hospitales , Regulación Gubernamental , Servicio Ambulatorio en Hospital/economía , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA